Our previous prospective randomized placebo-controlled study showed that RKT combined with a standard-dose of rabeprazole ( RPZ ) significantly improved the acid-related dysmotility symptoms ( ARD ) in elderly patients with proton pump inhibitor ( PPI ) - refractory non-erosive reflux disease ( NERD ) .